NILOTINIB VIATRIS 50 mg, hard capsule 120 capsules
Active ingredients: Nilotinib hydrochloride dihydrate, Nilotinib
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule120 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NILOTINIB VIATRIS 50 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquettes PVC polyéthylène PVDC aluminium de 120 gélules
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65628437CIP73030314CIP133400930303146Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE NILOTINIB DIHYDRATÉgélule | — | SA |
| NILOTINIBgélule | 50 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.